Literature DB >> 20154601

Infectious risk associated with arterial catheters compared with central venous catheters.

Jean-Christophe Lucet1, Lila Bouadma, Jean-Ralph Zahar, Carole Schwebel, Arnaud Geffroy, Sebastian Pease, Marie-Christine Herault, Hakim Haouache, Christophe Adrie, Marie Thuong, Adrien Français, Maïté Garrouste-Orgeas, Jean-François Timsit.   

Abstract

BACKGROUND: Scheduled replacement of central venous catheters and, by extension, arterial catheters, is not recommended because the daily risk of catheter-related infection is considered constant over time after the first catheter days. Arterial catheters are considered at lower risk for catheter-related infection than central venous catheters in the absence of conclusive evidence.
OBJECTIVES: To compare the daily risk and risk factors for colonization and catheter-related infection between arterial catheters and central venous catheters.
METHODS: We used data from a trial of seven intensive care units evaluating different dressing change intervals and a chlorhexidine-impregnated sponge. We determined the daily hazard rate and identified risk factors for colonization using a marginal Cox model for clustered data.
RESULTS: We included 3532 catheters and 27,541 catheter-days. Colonization rates did not differ between arterial catheters and central venous catheters (7.9% [11.4/1000 catheter-days] and 9.6% [11.1/1000 catheter-days], respectively). Arterial catheter and central venous catheter catheter-related infection rates were 0.68% (1.0/1000 catheter-days) and 0.94% (1.09/1000 catheter-days), respectively. The daily hazard rate for colonization increased steadily over time for arterial catheters (p = .008) but remained stable for central venous catheters. Independent risk factors for arterial catheter colonization were respiratory failure and femoral insertion. Independent risk factors for central venous catheter colonization were trauma or absence of septic shock at intensive care unit admission, femoral or jugular insertion, and absence of antibiotic treatment at central venous catheter insertion.
CONCLUSIONS: The risks of colonization and catheter-related infection did not differ between arterial catheters and central venous catheters, indicating that arterial catheter use should receive the same precautions as central venous catheter use. The daily risk was constant over time for central venous catheter after the fifth catheter day but increased significantly over time after the seventh day for arterial catheters. Randomized studies are needed to investigate the impact of scheduled arterial catheter replacement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20154601     DOI: 10.1097/CCM.0b013e3181d4502e

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  25 in total

1.  Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM).

Authors:  A Rhodes; R P Moreno; E Azoulay; M Capuzzo; J D Chiche; J Eddleston; R Endacott; P Ferdinande; H Flaatten; B Guidet; R Kuhlen; C León-Gil; M C Martin Delgado; P G Metnitz; M Soares; C L Sprung; J F Timsit; A Valentin
Journal:  Intensive Care Med       Date:  2012-01-26       Impact factor: 17.440

Review 2.  Arterial Catheterization and Infection: Toll-like Receptors in Defense against Microorganisms and Therapeutic Implications.

Authors:  Zakary J Hambsch; Mitchell J Kerfeld; Daniel R Kirkpatrick; Dan M McEntire; Mark D Reisbig; Charles F Youngblood; Devendra K Agrawal
Journal:  Clin Transl Sci       Date:  2015-08-14       Impact factor: 4.689

3.  Lower catheter-related bloodstream infection in arterial than in venous femoral catheter.

Authors:  L Lorente; A Jiménez; M M Martín; C Naranjo; I Roca; M L Mora
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-07-07       Impact factor: 3.267

4.  Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study.

Authors:  J Masse; A Elkalioubie; C Blazejewski; G Ledoux; F Wallet; J Poissy; S Preau; S Nseir
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-20       Impact factor: 3.267

5.  Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).

Authors:  Silvia Calviño Günther; Carole Schwebel; Rebecca Hamidfar-Roy; Agnès Bonadona; Maxime Lugosi; Claire Ara-Somohano; Clémence Minet; Leïla Potton; Jean-Charles Cartier; Aurelien Vésin; Magalie Chautemps; Lenka Styfalova; Stephane Ruckly; Jean-François Timsit
Journal:  Intensive Care Med       Date:  2016-10-12       Impact factor: 17.440

6.  Safety and Efficacy of Mobility Interventions in Patients with Femoral Catheters in the ICU: A Prospective Observational Study.

Authors:  Christiane Perme; Theresa Nalty; Chris Winkelman; Ricardo Kenji Nawa; Faisal Masud
Journal:  Cardiopulm Phys Ther J       Date:  2013-06

7.  Molecular investigation of bacterial communities on intravascular catheters: no longer just Staphylococcus.

Authors:  L Zhang; J Gowardman; M Morrison; L Krause; E G Playford; C M Rickard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-06       Impact factor: 3.267

Review 8.  A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.

Authors:  Jean-François Timsit; Mark Rupp; Emilio Bouza; Vineet Chopra; Tarja Kärpänen; Kevin Laupland; Thiago Lisboa; Leonard Mermel; Olivier Mimoz; Jean-Jacques Parienti; Garyphalia Poulakou; Bertrand Souweine; Walter Zingg
Journal:  Intensive Care Med       Date:  2018-05-12       Impact factor: 17.440

Review 9.  Implantable Device-Related Infection.

Authors:  J Scott VanEpps; John G Younger
Journal:  Shock       Date:  2016-12       Impact factor: 3.454

10.  Temporal trends in the use of parenteral nutrition in critically ill patients.

Authors:  Hayley B Gershengorn; Jeremy M Kahn; Hannah Wunsch
Journal:  Chest       Date:  2014-03-01       Impact factor: 9.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.